Annual Total Expenses
$26.35 M
-$10.34 M-28.17%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual total expenses is $26.35 million, with the most recent change of -$10.34 million (-28.17%) on December 31, 2021.
- During the last 3 years, IDRA annual total expenses has fallen by -$30.91 million (-53.98%).
Performance
IDRA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Expenses
$3.74 M
-$1.63 M-30.33%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly total expenses is $3.74 million, with the most recent change of -$1.63 million (-30.33%) on September 30, 2022.
- Over the past year, IDRA quarterly total expenses has dropped by -$2.10 million (-35.97%).
Performance
IDRA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
IDRA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.2% | -36.0% |
| 3 y3 years | -54.0% | -67.2% |
| 5 y5 years | -60.2% | -74.8% |
IDRA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -30.3% | at low |
| 5 y | 5-year | -44.3% | at low | -71.6% | at low |
| alltime | all time | -60.2% | -135.8% | -82.8% | -574.8% |
Idera Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.74 M(-30.3%) |
| Jun 2022 | - | $5.37 M(+28.3%) |
| Mar 2022 | - | $4.18 M(+1.5%) |
| Dec 2021 | $26.35 M(-28.2%) | $4.12 M(-29.4%) |
| Sep 2021 | - | $5.84 M(-8.3%) |
| Jun 2021 | - | $6.37 M(-36.5%) |
| Mar 2021 | - | $10.03 M(+24.7%) |
| Dec 2020 | $36.69 M(-22.5%) | $8.04 M(+7.4%) |
| Sep 2020 | - | $7.48 M(-6.6%) |
| Jun 2020 | - | $8.01 M(-39.1%) |
| Mar 2020 | - | $13.15 M(+11.6%) |
| Dec 2019 | $47.33 M(-17.3%) | $11.79 M(+3.6%) |
| Sep 2019 | - | $11.38 M(-11.9%) |
| Jun 2019 | - | $12.92 M(+14.9%) |
| Mar 2019 | - | $11.24 M(-10.0%) |
| Dec 2018 | $57.26 M(-13.6%) | $12.50 M(-2.7%) |
| Sep 2018 | - | $12.84 M(-13.7%) |
| Jun 2018 | - | $14.88 M(-12.7%) |
| Mar 2018 | - | $17.04 M(+21.1%) |
| Dec 2017 | $66.24 M(+20.5%) | $14.06 M(-5.2%) |
| Sep 2017 | - | $14.83 M(-31.9%) |
| Jun 2017 | - | $21.78 M(+39.9%) |
| Mar 2017 | - | $15.57 M(+7.1%) |
| Dec 2016 | $54.96 M(+11.9%) | $14.54 M(+9.3%) |
| Sep 2016 | - | $13.30 M(-4.4%) |
| Jun 2016 | - | $13.91 M(+5.3%) |
| Mar 2016 | - | $13.21 M(+7.7%) |
| Dec 2015 | $49.09 M(+26.5%) | $12.27 M(+6.9%) |
| Sep 2015 | - | $11.48 M(-10.1%) |
| Jun 2015 | - | $12.78 M(+1.8%) |
| Mar 2015 | - | $12.56 M(+5.2%) |
| Dec 2014 | $38.83 M(+113.1%) | $11.93 M(+24.9%) |
| Sep 2014 | - | $9.55 M(+14.2%) |
| Jun 2014 | - | $8.37 M(-6.8%) |
| Mar 2014 | - | $8.98 M(+47.7%) |
| Dec 2013 | $18.22 M(-8.7%) | $6.08 M(+29.6%) |
| Sep 2013 | - | $4.69 M(+30.4%) |
| Jun 2013 | - | $3.60 M(-6.7%) |
| Mar 2013 | - | $3.85 M(-11.2%) |
| Dec 2012 | $19.95 M(-23.0%) | $4.34 M(-8.7%) |
| Sep 2012 | - | $4.75 M(-11.2%) |
| Jun 2012 | - | $5.35 M(-2.7%) |
| Mar 2012 | - | $5.50 M(-24.0%) |
| Dec 2011 | $25.91 M(-24.0%) | $7.24 M(+31.1%) |
| Sep 2011 | - | $5.52 M(-12.5%) |
| Jun 2011 | - | $6.31 M(-7.8%) |
| Mar 2011 | - | $6.84 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $34.09 M(+25.7%) | $7.05 M(-29.3%) |
| Sep 2010 | - | $9.98 M(+2.4%) |
| Jun 2010 | - | $9.74 M(+33.2%) |
| Mar 2010 | - | $7.32 M(+13.2%) |
| Dec 2009 | $27.13 M(+4.6%) | $6.46 M(-0.6%) |
| Sep 2009 | - | $6.50 M(-13.9%) |
| Jun 2009 | - | $7.55 M(+13.9%) |
| Mar 2009 | - | $6.63 M(+8.1%) |
| Dec 2008 | $25.95 M(+14.3%) | $6.13 M(+4.2%) |
| Sep 2008 | - | $5.88 M(-15.8%) |
| Jun 2008 | - | $6.98 M(+0.5%) |
| Mar 2008 | - | $6.95 M(-1.4%) |
| Dec 2007 | $22.71 M(+19.6%) | $7.05 M(+27.9%) |
| Sep 2007 | - | $5.51 M(+2.6%) |
| Jun 2007 | - | $5.37 M(+12.6%) |
| Mar 2007 | - | $4.77 M(-10.7%) |
| Dec 2006 | $18.98 M(+16.5%) | $5.35 M(+21.4%) |
| Sep 2006 | - | $4.40 M(-11.5%) |
| Jun 2006 | - | $4.98 M(+17.0%) |
| Mar 2006 | - | $4.25 M(-20.1%) |
| Dec 2005 | $16.29 M(+17.5%) | $5.33 M(+52.4%) |
| Sep 2005 | - | $3.49 M(-12.9%) |
| Jun 2005 | - | $4.01 M(+15.9%) |
| Mar 2005 | - | $3.46 M(+14.3%) |
| Dec 2004 | $13.87 M(-24.2%) | $3.03 M(-26.9%) |
| Sep 2004 | - | $4.14 M(+25.2%) |
| Jun 2004 | - | $3.31 M(-2.2%) |
| Mar 2004 | - | $3.38 M(-22.4%) |
| Dec 2003 | $18.28 M(+34.1%) | $4.36 M(+8.7%) |
| Sep 2003 | - | $4.02 M(-5.9%) |
| Jun 2003 | - | $4.27 M(-24.3%) |
| Mar 2003 | - | $5.64 M(+67.1%) |
| Dec 2002 | $13.63 M(-244.5%) | $3.37 M(-40.9%) |
| Sep 2002 | - | $5.71 M(+140.8%) |
| Jun 2002 | - | $2.37 M(+11.6%) |
| Mar 2002 | - | $2.12 M(-112.0%) |
| Dec 2001 | -$9.44 M(-238.7%) | -$17.75 M(-975.7%) |
| Sep 2001 | - | $2.03 M(-47.2%) |
| Jun 2001 | - | $3.84 M(+56.7%) |
| Mar 2001 | - | $2.45 M(+46.5%) |
| Dec 2000 | $6.80 M(-28.0%) | $1.67 M(+26.2%) |
| Sep 2000 | - | $1.32 M(-23.7%) |
| Jun 2000 | - | $1.73 M(-16.4%) |
| Mar 2000 | - | $2.08 M |
| Dec 1999 | $9.45 M(-65.7%) | - |
| Dec 1998 | $27.55 M(-52.4%) | - |
| Dec 1997 | $57.85 M(+14.0%) | - |
| Dec 1996 | $50.74 M | - |
FAQ
- What is Idera Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual total expenses year-on-year change?
- What is Idera Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly total expenses year-on-year change?
What is Idera Pharmaceuticals annual total expenses?
The current annual total expenses of IDRA is $26.35 M
What is the all time high annual total expenses for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual total expenses is $66.24 M
What is Idera Pharmaceuticals annual total expenses year-on-year change?
Over the past year, IDRA annual total expenses has changed by -$10.34 M (-28.17%)
What is Idera Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of IDRA is $3.74 M
What is the all time high quarterly total expenses for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly total expenses is $21.78 M
What is Idera Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, IDRA quarterly total expenses has changed by -$2.10 M (-35.97%)